this study was to analyze the clinical efficacy and safety of Convalescent Plasma (CP) therapy in Corona Virus Disease 2019 (COVID-19) cases. Design: This was an experimental trial ... august 24, 2021. Findings: Pearson…
compare the effectiveness of shock wave therapy, platelet rich plasma injection (PRP) and topical insulin therapy on healing of diabetic foot ulcer. Methods: Sixty type II diabetic nonsmoker male patients
degenerative joint disorder characterized by cartilage deterioration, pain, and functional impairment. Platelet-rich plasma (PRP) therapy has emerged as a promising regenerative treatment due to its potential to…
component of blood that contains isotope specific antibodies such as IgA, IgG and IgM. Plasma therapy consists of transfusion of convalescent plasma to the COVID patients. The present investigation ... single center…
study the effectiveness of Convalescent Plasma Therapy (CPT) for combating COVID-19 diseases we have carried out a rapid of case series studies. Various academic publication related to convalescent plasma ... therapy…
quasi-experimental (prospective analytical) multi-center study of 65 patients who received convalescent plasma therapy (CPT). Results: Median age of patients who were given CPT was 60 years, were predominantly…
study the effectiveness of Convalescent Plasma Therapy (CPT) for combating COVID-19 diseases we have carried out a rapid of case series studies. Various academic publication related to convalescent plasma ... therapy…
Objective: To evaluate the effect of combining ultrasound-guided Platelet-Rich Plasma (PRP) therapy with physical therapy for rotator cuff tendinopathy. Design: We present a case report of rotator cuff ... tendinopathy…
plasma (CP) therapy is expected to increase the survivable rate. The history of convalescent plasma therapy dates back to the early 20th century. A plethora of studies suggest that ... systematic search in PubMed and…
recently regulated the use of platelet-rich plasma (PRP), that is,patient’s own plasma enriched in platelets and therefore in proteins and growth factors, as a human use drug ... first time that one regulatory agency…